LegalZoom to Participate in Upcoming Investor Conferences
GLENDALE, Calif., March 01, 2023 (GLOBE NEWSWIRE) -- LegalZoom.com, Inc. (Nasdaq: LZ) today announced its participation in the JMP Securities Technology......
Molecular Templates Announces Participation in Upcoming
AUSTIN, Texas, March 01, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage......
InnovAge Names Christine Bent as Chief Operations Officer
DENVER, March 01, 2023 (GLOBE NEWSWIRE) -- Today, InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), an industry leader in providing comprehensive......
Nature’s Sunshine Sets Fourth Quarter and Full Year 2022
LEHI, Utah, March 01, 2023 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (Nature’s Sunshine) (NASDAQ: NATR), a leading natural health and wellness......
Sana Biotechnology to Present at the Cowen 43rd Annual
[img]https://ml.globenewswire.com/Resource/Download/86b7f0b7-b317-402a-b600-8a26860a948e?size=1[/img]SEATTLE, March 01, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells...
Warner Music Group Corp. to Participate in Morgan Stanley
NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) -- Warner Music Group Corp. (“Warner Music Group” or “WMG”) announced today that Robert Kyncl, Chief Executive......
ZyVersa Therapeutics to Participate in a Fireside Chat at
CEO Stephen C. Glover to discuss key updates on the development status of ZyVersa’s Phase 2a-ready Cholesterol Efflux Mediator™ VAR 200 for renal disease,......
NGM Bio to Participate in the Cowen 43rd Annual Health Care
SOUTH SAN FRANCISCO, Calif., March 01, 2023 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a biotechnology company focused on......
Royalty Pharma Appoints Ashwin Pai as Executive Vice
NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Ashwin Pai, M.D. as Executive Vice......
BioNTech Announces Establishment of Interdisciplinary mRNA
JERUSALEM, Israel, March 1, 2023 – BioNTech SE (Nasdaq: BNTX, “BioNTech”, “the Company”) announced that the Company and the Weizmann Institute of Science......